Three novel missense mutations in the human lysosomal sialidase gene causing amino acid substitutions (P80L, W240R, and P316S) in the coding region were identified in two Japanese sialidosis patients.
- Henlius received exclusive license for two products in China (including Hong Kong, Macau, and Taiwan); Palleon retains all other global rights - WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--Palleon ...
- Bifunctional PD-L1-Targeted Sialidase exhibits enhanced efficacy compared to non-targeted sialidase or anti-PD-L1 antibody in mouse colon carcinoma model - WALTHAM, Mass.--(BUSINESS WIRE)--Palleon ...
WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the U.S.
WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today presented new preclinical data on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results